What Happened?
A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the healthcare industry showing significant job losses.
According to the Bureau of Labor Statistics, the economy lost 92,000 nonfarm payroll jobs, a stark reversal from the 50,000 gain that was anticipated by economists. The healthcare sector, typically a consistent source of job growth, shed 28,000 positions. This disappointing data has raised investor concerns about a potential economic slowdown, which could lead to reduced healthcare spending and demand for services, contributing to the sector's decline in the market.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks.
Among others, the following stocks were impacted:
- Surgical Equipment & Consumables - Specialty company Integra LifeSciences (NASDAQ: IART) fell 2.7%. Is now the time to buy Integra LifeSciences? Access our full analysis report here, it’s free.
- Medical Devices & Supplies - Imaging, Diagnostics company GE HealthCare (NASDAQ: GEHC) fell 2%. Is now the time to buy GE HealthCare? Access our full analysis report here, it’s free.
- Medical Devices & Supplies - Specialty company Bausch + Lomb (NYSE: BLCO) fell 2.8%. Is now the time to buy Bausch + Lomb? Access our full analysis report here, it’s free.
- Medical Devices & Supplies - Cardiology, Neurology, Vascular company ICU Medical (NASDAQ: ICUI) fell 3.9%. Is now the time to buy ICU Medical? Access our full analysis report here, it’s free.
- Hospital Chains company Universal Health Services (NYSE: UHS) fell 2%. Is now the time to buy Universal Health Services? Access our full analysis report here, it’s free.
Zooming In On ICU Medical (ICUI)
ICU Medical’s shares are somewhat volatile and have had 13 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The biggest move we wrote about over the last year was 7 months ago when the stock dropped 10.5% on the news that the company reported second-quarter results where a significant earnings beat was overshadowed by a year-over-year revenue decline and concerning cash flow performance.
The medical device company reported a GAAP profit of $1.43 per share, significantly reversing a loss from the prior year and handily beating analyst expectations. However, investors appeared to focus on the 8% year-over-year decline in revenue, which landed at $548.9 million, even though it slightly surpassed analyst forecasts. Furthermore, the company's free cash flow was a negative $8.49 million, a stark reversal from a positive $62.67 million in the same period last year, indicating pressure on its cash generation. Despite the company also issuing full-year profit guidance that was well ahead of Wall Street estimates, the revenue dip and negative cash flow seemingly weighed more heavily on investor sentiment.
ICU Medical is down 4.9% since the beginning of the year, and at $131.77 per share, it is trading 16.9% below its 52-week high of $158.54 from January 2026. Investors who bought $1,000 worth of ICU Medical’s shares 5 years ago would now be looking at an investment worth $665.34.
ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.
AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.
